A3 adenosine receptors:: Synthesis and biological evaluation of new potent and selective ligands

被引:0
|
作者
Volpini, R [1 ]
Lambertucci, C [1 ]
Taffi, S [1 ]
Vittori, S [1 ]
Klotz, KN [1 ]
Cristalli, G [1 ]
机构
[1] Univ Camerino, Dipartimento Sci Chim, I-62032 Camerino, Italy
来源
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
New polysubstituted adenosine derivatives were synthesized and tested at the four human adenosine receptor stably transfected into Chinese hamster ovary (CHO) cells, utilizing radioligand binding studies (A(1,), A(2A), A(3)) or adenylyl cyclase activity assay (A(2B)). Binding studies demonstrated that the presence of a phenylethynyl group in the 2 position of adenosine favoured the interaction with A(3) receptors leading to compounds endowed with high affinity and selectivity for the A(3) subtype. Further substitution of the N-6- and 4'-positions enhances the A(3) affinity and selectivity. In particular, the N-6-methoxy-2-phenyl-ethynyl-5'-N-methylcarboxamidoadenosine (5), showing K(i)A(3) = 1.9 nm and a selectivity A(1)/A(3) and A(2A)/A(3) of 4862 and 8670 fold, respectively, results one of the most potent and selective agonist at the human A(3) adenosine receptor subtype reported so far.
引用
收藏
页码:297 / 300
页数:4
相关论文
共 50 条
  • [31] N6-methoxy-2-alkynyladenosine derivatives as highly potent and selective ligands at the human A3 adenosine receptor
    Volpini, Rosaria
    Dal Ben, Diego
    Lambertucci, Catia
    Taffi, Sara
    Vittori, Sauro
    Klotz, Karl-Norbert
    Cristalli, Gloria
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (06) : 1222 - 1230
  • [32] Potent and selective ligands for adenosine binding sites
    Cristalli, G
    Camaioni, E
    DiFrancesco, E
    Eleuteri, A
    Vittori, S
    Volpini, R
    NUCLEOSIDES & NUCLEOTIDES, 1997, 16 (7-9): : 1379 - 1388
  • [33] Synthetic procedure for the preparation of novel potent and selective A3 adenosine receptor radioligands
    Volpini, R
    Costanzi, S
    Lambertucci, C
    Vittori, S
    Cristalli, G
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2001, 20 (4-7): : 775 - 779
  • [34] 8-Benzylaminoxanthine scaffold variations for selective ligands acting on adenosine A2A receptors. Design, synthesis and biological evaluation
    Zaluski, Michal
    Schabikowski, Jakub
    Jasko, Piotr
    Bryla, Adrian
    Olejarz-Maciej, Agnieszka
    Kaleta, Maria
    Gluch-Lutwin, Monika
    Brockmann, Andreas
    Hinz, Sonja
    Zygmunt, Malgorzata
    Kuder, Kamil
    Latacz, Gniewomir
    Vielmuth, Christin
    Mueller, Christa E.
    Kiec-Kononowicz, Katarzyna
    BIOORGANIC CHEMISTRY, 2020, 101
  • [35] Engineering of A3 adenosine and P2Y nucleotide receptors and their ligands
    Jacobson, KA
    Kim, HS
    Ravi, G
    Kim, SKY
    Lee, K
    Chen, AS
    Chen, WZ
    Kim, SG
    Barak, D
    Liang, BT
    Gao, ZG
    DRUG DEVELOPMENT RESEARCH, 2003, 58 (04) : 330 - 339
  • [36] Potent and selective A3 adenosine receptor antagonists bearing aminoesters as heterobifunctional moieties
    Federico, Stephanie
    Margiotta, Enrico
    Moro, Stefano
    Kachler, Sonja
    Klotz, Karl-Norbert
    Spalluto, Giampiero
    RSC MEDICINAL CHEMISTRY, 2021, 12 (02): : 254 - 262
  • [37] Synthesis and Biological Evaluation of 2-Alkynyl-N6-methyl-5′-N-methylcarboxamidoadenosine Derivatives as Potent and Highly Selective Agonists for the Human Adenosine A3 Receptor
    Volpini, Rosaria
    Buccioni, Michela
    Dal Ben, Diev
    Lambertucci, Catia
    Lammi, Carmen
    Marucci, Gabriella
    Ramadori, Anna T.
    Klotz, Karl-Norbert
    Cristalli, Gloria
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (23) : 7897 - 7900
  • [38] ADENOSINE A3 RECEPTORS: A NEW THERAPEUTIC APPROACH IN CANCER.
    Gaspar, Alexandra
    Silva, Tiago
    Borges, Fernanda
    QUIMICA NOVA, 2011, 34 (08): : 1417 - 1424
  • [39] Adenosine A3 receptors and cytokine production
    不详
    EXPERT OPINION ON THERAPEUTIC PATENTS, 1998, 8 (08) : 1049 - 1051
  • [40] Adenosine A3 receptors and viability of astrocytes
    Abbracchio, MP
    Ceruti, S
    Brambilla, R
    Barbieri, D
    Camurri, A
    Franceschi, C
    Giammarioli, AM
    Jacobson, KA
    Cattabeni, F
    Malorni, W
    DRUG DEVELOPMENT RESEARCH, 1998, 45 (3-4) : 379 - 386